384 results on '"Pfisterer, Matthias"'
Search Results
2. Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials
3. Prognostic Value of “Routine” Cardiac Stress Imaging 5 Years After Percutaneous Coronary Intervention: The Prospective Long-Term Observational BASKET (Basel Stent Kosteneffektivitäts Trial) LATE IMAGING Study
4. Heart failure with mid‐range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF)
5. Drug Eluting and Bare Metal Stents in People with and without Diabetes: Collaborative Network Meta-Analysis
6. Raised cardiac troponins: Causes extend beyond acute coronary syndromes
7. Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials
8. Impact of worsening renal function related to medication in heart failure
9. Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis
10. Drug-eluting stents with biodegradable polymers: are enough data in for a final assessment?
11. A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
12. Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts:Randomized Controlled Trial
13. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology
14. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)
15. Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF
16. Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial
17. Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents: An Observational Study of Drug-Eluting Versus Bare-Metal Stents
18. Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study
19. End-of-life preferences of elderly patients with chronic heart failure
20. Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME‐CHF trial
21. Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
22. Meeting Report: ESC Forum on Drug Eluting Stents European Heart House, Nice, 27–28 September 2007
23. Long-term benefit–risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET
24. MOESM1 of Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials
25. Sublingual administration of furosemide: new application of an old drug
26. Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study
27. Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET)
28. Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET)†
29. International variation in invasive care of the elderly with acute coronary syndromes
30. Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry
31. Limited diagnostic yield of non-invasive coronary angiography by 16-slice multi-detector spiral computed tomography in routine patients referred for evaluation of coronary artery disease
32. Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II
33. Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women:A pooled analysis of the basket-prove I and II trials
34. Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease☆: Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME)
35. Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina – on-treatment analysis of the TIME trial
36. Raised cardiac troponins
37. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients☆
38. Coronary artery disease and depression
39. Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease
40. Gate-keeper to coronary angiography: comparison of exercise testing, myocardial perfusion SPECT and individually tailored approach for risk stratification
41. How reliable are left ventricular ejection fraction cut offs assessed by echocardiography for clinical decision making in patients with heart failure?
42. Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trials
43. Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II
44. Bedside quantification of atherosclerosis severity for cardiovascular risk stratification: a prospective cohort study
45. Das Mausoleum von Belevi : Archäologische Untersuchungen zu Chronologie, Ausstattung und Stiftung
46. Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the proximal left anterior descending artery:An analysis of the BASKET-PROVE I and II trials
47. Interrelation of ST-segment depression during bicycle ergometry and extent of myocardial ischaemia by myocardial perfusion SPECT
48. Erhöhtes Risiko für Stentthrombosen bei DES?
49. Das Prytaneion in Ephesos
50. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.